Financhill
Buy
56

EMN Quote, Financials, Valuation and Earnings

Last price:
$77.77
Seasonality move :
-3.07%
Day range:
$77.14 - $78.74
52-week range:
$70.90 - $114.50
Dividend yield:
4.24%
P/E ratio:
9.89x
P/S ratio:
0.98x
P/B ratio:
1.53x
Volume:
910.4K
Avg. volume:
1.7M
1-year change:
-21.84%
Market cap:
$9B
Revenue:
$9.4B
EPS (TTM):
$7.86

Earnings Data

Next earnings date for EMN
Jul 31
2025
Most recent earnings per share
$1.57
Missed by $0.32
(Apr 24/2025)
Consensus Estimate
$1.89
(Apr 24/2025)

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

EMN Quarterly Earnings History

Date Quarter Revenue Forecast Actual Revenue Reported EPS Consensus EPS Beat/Miss
09/30/2025 Q3 $2.4B -- -- $1.91 --
07/31/2025 Q2 $2.3B -- -- $1.75 --
04/24/2025 Q1 $2.3B $2.3B $1.57 $1.89 -$0.32
01/30/2025 Q4 $2.3B $2.2B $2.82 $1.57 $1.25
10/31/2024 Q3 $2.4B $2.5B $1.53 $2.14 -$0.61
07/25/2024 Q2 $2.4B $2.4B $1.94 $2.01 -$0.07
04/25/2024 Q1 $2.3B $2.3B $1.39 $1.43 -$0.04
02/01/2024 Q4 $2.2B $2.2B $2.61 $1.30 $1.31
10/26/2023 Q3 $2.3B $2.3B $1.49 $1.45 $0.04
07/27/2023 Q2 $2.6B $2.3B $2.27 $1.94 $0.33
04/27/2023 Q1 -- $2.4B $1.12 -- --
01/26/2023 Q4 -- $2.4B $0.01 -- --
10/27/2022 Q3 -- $2.7B $2.46 -- --
07/28/2022 Q2 -- $2.8B $2.03 -- --
04/28/2022 Q1 -- $2.7B $1.80 -- --
01/27/2022 Q4 -- $2.7B $2.81 -- --
10/28/2021 Q3 -- $2.7B $2.57 -- --
08/02/2021 Q2 -- $2.7B -$1.07 -- --
04/29/2021 Q1 -- $2.4B $1.99 -- --
01/28/2021 Q4 -- $2.2B $0.23 -- --
10/29/2020 Q3 -- $2.1B $1.18 -- --
08/03/2020 Q2 -- $1.9B $0.20 -- --
04/30/2020 Q1 -- $2.2B $1.89 -- --
01/30/2020 Q4 -- $2.2B $0.19 -- --
10/24/2019 Q3 -- $2.3B $1.93 -- --
07/26/2019 Q2 -- $2.4B $1.85 -- --
04/25/2019 Q1 -- $2.4B $1.49 -- --
01/31/2019 Q4 -- $2.4B $0.24 -- --
10/25/2018 Q3 -- $2.5B $2.89 -- --
07/27/2018 Q2 -- $2.6B $2.39 -- --
04/26/2018 Q1 -- $2.6B $2.00 -- --
02/01/2018 Q4 -- $2.4B $4.01 -- --
10/26/2017 Q3 -- $2.5B $2.22 -- --
07/27/2017 Q2 -- $2.4B $2.00 -- --
04/27/2017 Q1 -- $2.3B $1.89 -- --
01/27/2017 Q4 -- $2.2B $0.87 -- --
10/27/2016 Q3 -- $2.3B $1.56 -- --
07/28/2016 Q2 -- $2.3B $1.71 -- --
04/29/2016 Q1 -- $2.2B $1.69 -- --
01/29/2016 Q4 -- $2.2B $0.83 -- --
10/30/2015 Q3 -- $2.4B $1.71 -- --

Eastman Chemical Earnings Questions

  • How Much did Eastman Chemical Generate in Revenue Last Quarter?

    Eastman Chemical reported $2.3B worth of top line sales in its most recent quarter.

  • Did Eastman Chemical Beat Earnings Last Quarter?

    Eastman Chemical announced earnings per share of $1.57 which represents a miss of analyst forecast a $1.89 per share.

  • Is Eastman Chemical Profitable?

    Eastman Chemical reported $567M that represents $4.87 per share over the last quarter.

  • What is the Analyst Consensus for Eastman Chemical EPS Next Year?

    Eastman Chemical's earnings are forecast to decrease from $7.67 per share to $7.57 per share next year representing a decrease of -4.48%.

  • When is Eastman Chemical's Earnings Date?

    Eastman Chemical's next earnings date is July 31, 2025.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Is Bloom Energy Flying Under the Radar?
Is Bloom Energy Flying Under the Radar?

Bloom Energy (NYSE:BE) manufactures scalable fuel cells for providing on-site…

Will GoodRX Stock Bounce Back?
Will GoodRX Stock Bounce Back?

GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…

Will FCX Benefit From Tariffs?
Will FCX Benefit From Tariffs?

Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…

Stock Ideas

Buy
70
Is NVDA Stock a Buy?

Market Cap: $4.2T
P/E Ratio: 59x

Buy
61
Is MSFT Stock a Buy?

Market Cap: $3.8T
P/E Ratio: 43x

Sell
42
Is AAPL Stock a Buy?

Market Cap: $3.2T
P/E Ratio: 35x

Alerts

Buy
55
TLN alert for Jul 19

Talen Energy [TLN] is up 24.44% over the past day.

Sell
48
CRSP alert for Jul 19

CRISPR Therapeutics AG [CRSP] is up 18.22% over the past day.

Buy
83
SOC alert for Jul 19

Sable Offshore [SOC] is up 11.86% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock